Donor‐specific alloantibodies in liver transplantation: how should we define and improve long‐term success?

Publisher： John Wiley & Sons Inc

E-ISSN： 1432-2277|28|12|1359-1361

ISSN： 0934-0874

Source： TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol.28, Iss.12, 2015-12, pp. : 1359-1361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

How to improve long‐term outcome after liver transplantation?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. S1, 2018-02 ,pp. : 134-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of IgG3 Subclass and C1q‐Fixing Donor‐Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 4, 2015-04 ,pp. : 1003-1013

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dual‐graft adult living donor liver transplantation with ABO‐incompatible graft: short‐term and long‐term outcomes

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 2, 2018-02 ,pp. : 424-433

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term follow‐up of biliary complications after adult right‐lobe living donor liver transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 5, 2015-05 ,pp. : 465-474

John Wiley & Sons Inc

Access to resources Recommend Favorite

CMV Primary Infection Is Associated With Donor‐Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 9, 2015-09 ,pp. : 2431-2442

John Wiley & Sons Inc

Access to resources Recommend Favorite